Abstract:There has been growing tension at the intersection of health and economic policymaking as global governance has increased across sectors. This tension has been particularly evident between tobacco control and trade policy, as the international norms that frame them – particularly the Framework Convention on Tobacco Control and the World Trade Organization (WTO) – have continued to institutionalize. Using five case studies of major tobacco-related trade disputes from the principal multilateral system of trade g… Show more
“…Tobacco-related disease kills nearly six million people each year, with populations in LMICs increasingly at risk (137). These health challenges will continue to grow rapidly as tobacco companies push aggressively into developing countries with young populations, growing incomes, and often relatively weak political systems (31). Trade liberalization has increased both the imports of tobacco products into countries worldwide and the levels of FDI by the tobacco industry.…”
Section: Unhealthy Commoditiesmentioning
confidence: 99%
“…The FCTC may be used to interpret international trade and investment agreements, making those agreements more sensitive to tobacco control (31). However, the provisions set out in the FCTC have been repeatedly challenged under international trade law (84).…”
Twenty-first-century trade policy is complex and affects society and population health in direct and indirect ways. Without doubt, trade policy influences the distribution of power, money, and resources between and within countries, which in turn affects the natural environment; people's daily living conditions; and the local availability, quality, affordability, and desirability of products (e.g., food, tobacco, alcohol, and health care); it also affects individuals' enjoyment of the highest attainable standard of health. In this article, we provide an overview of the modern global trade environment, illustrate the pathways between trade and health, and explore the emerging twenty-first-century trade policy landscape and its implications for health and health equity. We conclude with a call for more interdisciplinary research that embraces complexity theory and systems science as well as the political economy of health and that includes monitoring and evaluation of the impact of trade agreements on health.
“…Tobacco-related disease kills nearly six million people each year, with populations in LMICs increasingly at risk (137). These health challenges will continue to grow rapidly as tobacco companies push aggressively into developing countries with young populations, growing incomes, and often relatively weak political systems (31). Trade liberalization has increased both the imports of tobacco products into countries worldwide and the levels of FDI by the tobacco industry.…”
Section: Unhealthy Commoditiesmentioning
confidence: 99%
“…The FCTC may be used to interpret international trade and investment agreements, making those agreements more sensitive to tobacco control (31). However, the provisions set out in the FCTC have been repeatedly challenged under international trade law (84).…”
Twenty-first-century trade policy is complex and affects society and population health in direct and indirect ways. Without doubt, trade policy influences the distribution of power, money, and resources between and within countries, which in turn affects the natural environment; people's daily living conditions; and the local availability, quality, affordability, and desirability of products (e.g., food, tobacco, alcohol, and health care); it also affects individuals' enjoyment of the highest attainable standard of health. In this article, we provide an overview of the modern global trade environment, illustrate the pathways between trade and health, and explore the emerging twenty-first-century trade policy landscape and its implications for health and health equity. We conclude with a call for more interdisciplinary research that embraces complexity theory and systems science as well as the political economy of health and that includes monitoring and evaluation of the impact of trade agreements on health.
“…Canada has also been opposing almost every effort by the US to extend patent protection in the TPPA beyond provisions in the World Trade Organization's TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement 16 and has used public health arguments to defend its ban on certain tobacco flavourings in committee meetings at the World Trade Organization. 17 So there may be some room for a stronger global public health presence in Canadian trade policy to guide how the post-2015 goals on trade are implemented.…”
Section: Canada and The Aid/trade Agendamentioning
A new set of post-2015 development goals for the world is being negotiated. Several potential goals relating to sustainable development, poverty, the economy and health have been identified. Many of them have potential public health gains, although there are inadequacies in how several of them have been defined. In participating in finalization of these goals, Canada should strengthen its commitments to maternal/child health; promote its publicly funded health system as an important model for universal health coverage; incorporate stronger protections for public health in trade and investment treaties; use its foreign aid to help low-and middle-income countries build the transparent and progressive tax systems to mobilize domestic revenues for health; and promote global systems of taxation to prevent tax evasion and illicit capital flight.KEY WORDS: Public health; social determinants of health; world health La traduction du résumé se trouve à la fin de l'article.
“…Efforts to generate global momentum for advanced tobacco packaging and labelling laws has some scholars labelling this progress as ‘too hot for regulatory chill’ (Lencucha, Labonte, & Drope, 2015). This success can be partially attributed to the evolution of the intersection between tobacco and trade (referred to as the tobacco-trade nexus), in which the global discourse on tobacco norms has been integrated in international trade and investment discussions and decisions (Drope & Lencucha, 2013, 2014). These norms have been further institutionalised through the adoption of the WHO Framework Convention on Tobacco Control (FCTC), which established a set of guidelines, obligations, and standards for treaty parties to reduce tobacco use (World Health Organization, 2003).…”
This study examines how health advocates and the Australian government responded to international commercial pressure during the implementation of tobacco standardised packaging (SP) as a measure to reduce non-communicable diseases (NCDs). Relevant government and NGO documents, and media items were reviewed. Policymakers and health advocates (n = 19) in Australia were interviewed. In 2009, Australia’s National Health Taskforce recommended SP, which the Australian government announced in April 2010. In response, tobacco companies threatened the government with litigation in both domestic and international courts, claiming that SP would violate their investment and intellectual property rights. However, these legal threats were unsuccessful in forcing the government to withdrawal the SP proposal. Tobacco companies legally challenged SP, but as of February 2018 failed with each legal challenge. The political success of enacting and implementing SP against international commercial pressure was supported by legal preparation and support, and a whole-of-government approach. The Australian SP case illustrates how, against international commercial opposition, governments can build and maintain political and official support to enact and implement progressive public health measures to reduce NCDs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.